Medtronic launches renal stent system in Europe:
This article was originally published in Clinica
Medtronic has launched its next-generation renal stent system, the Bridge X3, in Europe and other major markets outside the US. The device has a low crossing profile - it can be delivered through a 6 French sheath - it has high radial strength and has improved scaffolding due to having shorter element lengths, the company says. The product is not for sale in the US, where it is an investigational device.
You may also be interested in...
Vertex is hoping for EU approval in Q4 of its cystic fibrosis triple combination therapy, Trikafta. It wants the same licence in the EU as it has in the US, where the product has already become a best seller for the company.
Sawai’s sales increased on the back of a good performance from recently-launched products in the first nine months of its financial year. However, given the competitive environment the Japanese company is continuing to stick to its full-year forecasts.